Nisa Investment Advisors, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Nisa Investment Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$13.58 - $17.36 $841 - $1,076	62 Added 0.27%	23,002 $361,000
Q4 2023 Jan 25, 2024	SELL	$10.11 - $16.54 $23,253 - $38,042	-2,300 Reduced 9.11%	22,940 $370,000
Q3 2023 Nov 02, 2023	BUY	$12.46 - $15.48 $49 - $61	4 Added 0.02%	25,240 $321,000
Q2 2023 Aug 11, 2023	BUY	$13.28 - $15.96 $7,516 - $9,033	566 Added 2.29%	25,236 $355,000
Q1 2023 May 02, 2023	SELL	$14.26 - $22.1 $24,926 - $38,630	-1,748 Reduced 6.62%	24,670 $381,000
Q3 2022 Nov 07, 2022	BUY	$12.38 - $20.23 $470 - $768	38 Added 0.14%	26,418 $479,000
Q1 2022 Apr 29, 2022	SELL	$6.87 - $11.11 $36,493 - $59,016	-5,312 Reduced 16.76%	26,380 $245,000
Q4 2021 Feb 03, 2022	BUY	$7.7 - $37.13 $231,862 - $1.12 Million	30,112 Added 1905.82%	31,692 $267,000
Q2 2021 Aug 06, 2021	SELL	$32.73 - $47.95 $1,636 - $2,397	-50 Reduced 3.07%	1,580 $58,000
Q4 2020 Jan 25, 2021	BUY	$51.77 - $66.18 $5,177 - $6,618	100 Added 6.54%	1,630 $93,000
Q3 2020 Oct 20, 2020	BUY	$43.8 - $58.16 $50,370 - $66,884	1,150 Added 302.63%	1,530 $78,000
Q2 2020 Jul 27, 2020	BUY	$37.05 - $65.03 $14,078 - $24,711	380 New	380 $23,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.